Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders
Study Details
Study Description
Brief Summary
RATIONALE: Learning about the side effects of stereotactic radiosurgery in patients with brain tumors or other brain disorders may help doctors plan treatment and help patients live more comfortably.
PURPOSE: This clinical trial is studying the acute side effects in patients who are undergoing stereotactic radiosurgery for brain tumors or other brain disorders.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
OBJECTIVES:
-
Determine the incidence and types of acute complications in patients undergoing stereotactic radiosurgery for brain tumors or other brain disorders.
-
Determine the time frame for development and resolution of these complications in these patients.
-
Determine the severity of these complications in these patients.
OUTLINE: Patients undergo stereotactic radiosurgery. Patients also complete questionnaires about the side effects they experience from radiosurgery. The questionnaires are completed at baseline and at 1 week, 1 month, and 2 months after radiosurgery.
PROJECTED ACCRUAL: A total of 94 patients will be accrued for this study.
Study Design
Outcome Measures
Primary Outcome Measures
- Short-term adverse effects as assessed by a questionnaire [at 1 week, 1 month, and 2 months]
Patients undergo stereotactic radiosurgery. Patients also complete questionnaires about the side effects they experience from radiosurgery. The questionnaires are completed at baseline and at 1 week, 1 month, and 2 months after radiosurgery.
Eligibility Criteria
Criteria
DISEASE CHARACTERISTICS:
-
Diagnosis of brain tumor or other brain disorder, including, but not limited to, 1 of the following:
-
Primary brain tumors
-
Brain metastases
-
Acoustic neuromas
-
Pituitary adenomas
-
Parkinson's disease
-
Cluster headaches
-
Glomus jugulare
-
Epilepsy
-
Obsessive compulsive disorder
-
Arteriovenous malformations
-
Trigeminal neuralgia
-
Eligible for and scheduled to undergo stereotactic radiosurgery
PATIENT CHARACTERISTICS:
Performance status
- Not specified
Life expectancy
- Not specified
Hematopoietic
- Not specified
Hepatic
- Not specified
Renal
- Not specified
Other
- No physical or mental limitation that would preclude study compliance
PRIOR CONCURRENT THERAPY:
Endocrine therapy
- Concurrent steroids allowed
Radiotherapy
- No prior stereotactic radiosurgery
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Cleveland Clinic Taussig Cancer Center | Cleveland | Ohio | United States | 44195 |
Sponsors and Collaborators
- Case Comprehensive Cancer Center
Investigators
- Principal Investigator: John Suh, MD, Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- CASE4Z05